CORTISONE ACETATE

Post-LOE

cortisone acetate

Hikma

ANDAORALTABLET

Approved

Jun 1972

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

CORTISONE ACETATE (cortisone acetate) by Hikma is clinical pharmacology: naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Approved for stress, fatigue, simple nervous tension. First approved in 1972.

Drug data last refreshed 20h ago

Mechanism of Action

CLINICAL PHARMACOLOGY: Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders of many organ…

Indications (3)

stress fatigue

Worked on CORTISONE ACETATE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

CORTISONE ACETATE

Mechanism of Action

Indications (3)

Clinical Trials (1)